retatrutide and alcohol use Why I’m Quitting Alcohol, Side Effects & Getting Leaner After Greece GLP-1 medications: The next big

GLP-1 receptor agonists, including semaglutide, reduce alcohol intake and relapse-like behaviors in rodent and non-human primate models, and a recent clinical trial found that semaglutide decreased alcohol craving and drinking in adults with AUD

Slow titration improved adherence

Table 2 Overview of GLP-1 receptor agonists (GLP-1RAs) approved by the EMA and/or FDA, with year of authorization and main therapeutic indications

Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement

Patients often report: A decreased need to graze or constantly snack

But clear evidence from people was lacking